Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: 2-Year Results: Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group

OBJECTIVE: To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for two years and to describe the impact of switching to as-needed treatment after a year of monthly treatment. DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: Patients (N=1107) who wer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Martin, Daniel F., Maguire, Maureen G., Fine, Stuart L., Ying, Gui-shuang, Jaffe, Glenn J., Grunwald, Juan E., Toth, Cynthia, Redford, Maryann, Ferris, Frederick L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389193/
https://ncbi.nlm.nih.gov/pubmed/22555112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.03.053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados